|
|
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Number of employees : 48 000 people.
|
|
|
| 2019 | 2020 | Delta | | Pharmaceutical | 129 917.00 | 89.3% | 137 495.00 | 89.9% | +5.83% |
| Medical | 15 633.00 | 10.7% | 15 444.00 | 10.1% | -1.21% |
| USD in Million |
|
|
|
| 2019 | 2020 | Delta | | United States | 141 479.00 | 97.2% | 148 707.00 | 97.2% | +5.11% |
| International | 4 071.00 | 2.8% | 4 232.00 | 2.8% | +3.95% |
| USD in Million |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
326,147,927 |
289,655,314 |
88.8% |
36,000,000 |
11.0% |
88.8% |
|
|
|
| Name | Equities | % | | The Vanguard Group, Inc. | 34,799,260 |
12.0% | | Capital Research & Management Co. | 28,663,000 |
9.88% | | SSgA Funds Management, Inc. | 17,490,396 |
6.03% | | Macquarie Investment Management Business Trust | 11,033,449 |
3.80% | | T. Rowe Price Associates, Inc. (Investment Management) | 9,646,259 |
3.32% | | BlackRock Fund Advisors | 7,312,583 |
2.52% | | Geode Capital Management LLC | 5,346,029 |
1.84% | | American Century Investment Management, Inc. | 5,121,701 |
1.77% | | Greenlight Capital, Inc. | 4,602,200 |
1.59% | | Fidelity Management & Research Co. LLC | 4,128,788 |
1.42% |
|
| Company contact information |
|
|
|
|
|
Frontline advocates view $26 billion opioid deal with frustration, worry |
Sector Other Drug Retailers
| | 1st jan. | Capi. (M$) |
 | CARDINAL HEALTH, INC. | 11.22% | 17 302 |
| | | |
| WALGREENS BOOTS ALLIANCE, INC. | 19.08% | 41 078 |
| MCKESSON CORPORATION | 18.69% | 31 926 |
 | JD HEALTH INTERNATIONAL INC. | -51.10% | 30 049 |
 | HUADONG MEDICINE CO., LTD | 41.64% | 10 174 |
| SINOPHARM GROUP CO., LTD. | 12.41% | 8 506 |
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | 1.46% | 7 737 |
 | WELCIA HOLDINGS CO., LTD. | -5.65% | 7 014 |
| YIFENG PHARMACY CHAIN CO., LTD. | -27.09% | 5 619 |
| DASHENLIN PHARMACEUTICAL GROUP CO., LTD. | -33.04% | 5 340 |
 | CLICKS GROUP LIMITED | 7.73% | 4 659 |
| MATSUMOTOKIYOSHI HOLDINGS CO., LTD. | 7.95% | 4 435 |
| MEDIPAL HOLDINGS CORPORATION | 9.34% | 4 079 |
| JOINTOWN PHARMACEUTICAL GROUP CO., LTD. | -20.76% | 4 067 |
 | GALENICA AG | 20.93% | 3 904 |
| CHINA NATIONAL MEDICINES CORPORATION LTD. | -36.38% | 3 658 |
 | EBOS GROUP LIMITED | 8.40% | 3 563 |
| ZUR ROSE GROUP AG | 13.43% | 3 400 |
| YIXINTANG PHARMACEUTICAL GROUP CO., LTD. | -6.24% | 2 878 |
 | SHOP APOTHEKE EUROPE N.V. | -16.94% | 2 641 |
| SUZUKEN CO., LTD. | -12.60% | 2 633 |
Connections : Cardinal Health, Inc. |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
